
Scientific Publications
< Back to Publications
Molecular sampling of prostate cancer: a dilemma for predicting disease progression.
| Publication Type | Journal Article |
| Authors | Sboner, A., Demichelis F., Calza S., Pawitan Y., Setlur SR, Hoshida Y., Perner S., Adami HO, Fall K., Mucci LA, Kantoff PW, Stampfer M., Andersson SO, Varenhorst E., Johansson JE, Gerstein MB, Golub T. R., Rubin MA, and Andrén O. |
| Abstract | Current prostate cancer prognostic models are based on pre-treatment prostate specific antigen (PSA) levels, biopsy Gleason score, and clinical staging but in practice are inadequate to accurately predict disease progression. Hence, we sought to develop a molecular panel for prostate cancer progression by reasoning that molecular profiles might further improve current clinical models. |
| Year of Publication | 2010 |
| Journal | BMC medical genomics |
| Volume | 3 |
| Pages | 8 |
| Date Published (YYYY/MM/DD) | 2010/03/16 |
| DOI | 10.1186/1755-8794-3-8 |
| PubMed | http://www.ncbi.nlm.nih.gov/pubmed/20233430?dopt=Abstract |




